TrialThrombosis and haemostasis2021

Pharmacokinetics and Pharmacodynamics of Emicizumab in Persons with Hemophilia A with Factor VIII Inhibitors: HAVEN 1 Study.

Christophe Schmitt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.